Stem Cells Bank SA - Sistemul Medical Medlife

stemcellsbank.ro

Stem Cells Bank is a cord blood bank in Timisoara, Romania, created in 2010 and offering stem cell storage services in Romania and the neighbouring countries. The company has set up an advanced biotechnology laboratory, operating under the strictest European and national regulations. Stem Cells Bank is open to partnerships regarding stem cells banking, applications and biotechnology services in general.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MedTech, Industrial Impact

GENERATE BIOMEDICINES EXPANDS LEADERSHIP TEAM WITH CHIEF DIGITAL OFFICER

Generate Biomedicines | December 07, 2022

news image

Generate Biomedicines announced that Dimitris Agrafiotis, Ph.D., FRSC, has been appointed Chief Digital Officer. He will lead multidisciplinary teams across technology, data science, automation, and digital transformation to support the rapid growth of the machine learning-powered biotech. Dr. Agrafiotis brings deep expertise at the intersection of digital technology, data science, and life sciences spanning the entire R&D continuum across venture-funded biotech, big pharma, a...

Read More

Cell and Gene Therapy

BIOMARIN AND SKYLINE THERAPEUTICS ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP NOVEL GENE THERAPIES FOR CARDIOVASCULAR DISEASES

BioMarin Pharmaceutical Inc. | December 17, 2021

news image

BioMarin Pharmaceutical Inc. and Skyline Therapeutics a gene and cell therapy company focused on developing novel treatments for unmet medical needs, announced a multi-year global strategic collaboration for the discovery, development and commercialization of Adeno-Associated Virus gene therapies to treat genetic cardiovascular diseases. The partnership will leverage Skyline Therapeutics' integrated AAV gene therapy platform based on its proprietary vector engineer...

Read More

Cell and Gene Therapy

TUNE THERAPEUTICS LAUNCHES WITH PIONEERING EPIGENOMIC CONTROL PLATFORM TO MASTER GENE NETWORKS, TREAT BROAD RANGE OF DISEASES

Tune Therapeutics | December 03, 2021

news image

Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched today with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology dials gene expression up or down to desired levels – with the potential to reverse pathways of cancer, genetic disease, and aging by changing cell fate and function at will. "Genetic medicine is at a tipping point. We now understand that the driving...

Read More

SARTORIUS STEDIM BIOTECH CLOSES ACQUISITION OF SLOVENIAN PURIFICATION SPECIALIST BIA SEPARATIONS

Sartorius | November 03, 2020

news image

Sartorius Stedim Biotech (SSB), a leading partner of the biopharma industry, successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the required approvals. "BIA's portfolio is highly complementary to Sartorius Stedim Biotech. We are thus creating an excellent offering for the manufacturing of gene therapies and other advanced therapies, and are pleased to welcome 120 new employees,&...

Read More
news image

MedTech, Industrial Impact

GENERATE BIOMEDICINES EXPANDS LEADERSHIP TEAM WITH CHIEF DIGITAL OFFICER

Generate Biomedicines | December 07, 2022

Generate Biomedicines announced that Dimitris Agrafiotis, Ph.D., FRSC, has been appointed Chief Digital Officer. He will lead multidisciplinary teams across technology, data science, automation, and digital transformation to support the rapid growth of the machine learning-powered biotech. Dr. Agrafiotis brings deep expertise at the intersection of digital technology, data science, and life sciences spanning the entire R&D continuum across venture-funded biotech, big pharma, a...

Read More
news image

Cell and Gene Therapy

BIOMARIN AND SKYLINE THERAPEUTICS ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP NOVEL GENE THERAPIES FOR CARDIOVASCULAR DISEASES

BioMarin Pharmaceutical Inc. | December 17, 2021

BioMarin Pharmaceutical Inc. and Skyline Therapeutics a gene and cell therapy company focused on developing novel treatments for unmet medical needs, announced a multi-year global strategic collaboration for the discovery, development and commercialization of Adeno-Associated Virus gene therapies to treat genetic cardiovascular diseases. The partnership will leverage Skyline Therapeutics' integrated AAV gene therapy platform based on its proprietary vector engineer...

Read More
news image

Cell and Gene Therapy

TUNE THERAPEUTICS LAUNCHES WITH PIONEERING EPIGENOMIC CONTROL PLATFORM TO MASTER GENE NETWORKS, TREAT BROAD RANGE OF DISEASES

Tune Therapeutics | December 03, 2021

Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched today with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology dials gene expression up or down to desired levels – with the potential to reverse pathways of cancer, genetic disease, and aging by changing cell fate and function at will. "Genetic medicine is at a tipping point. We now understand that the driving...

Read More
news image

SARTORIUS STEDIM BIOTECH CLOSES ACQUISITION OF SLOVENIAN PURIFICATION SPECIALIST BIA SEPARATIONS

Sartorius | November 03, 2020

Sartorius Stedim Biotech (SSB), a leading partner of the biopharma industry, successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the required approvals. "BIA's portfolio is highly complementary to Sartorius Stedim Biotech. We are thus creating an excellent offering for the manufacturing of gene therapies and other advanced therapies, and are pleased to welcome 120 new employees,&...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us